Home
Live Updates
Third Rock, J&J neuroscience spinout Rapport outlines IPO plans : comparemela.com
Third Rock, J&J neuroscience spinout Rapport outlines IPO plans
The new year burst of biotech IPOs may have sputtered out months ago, but Rapport is a reminder that companies are still willing to test the waters
Related Keywords
Abe Ceesay ,
David Bredt ,
Eli Lilly ,
Johnson ,
Exchange Commission ,
Nasdaq ,
Rapport Therapeutics ,
Third Rock ,
Third Rock Ventures ,
Arch Venture Partners ,
Johnson Innovation ,
Fierce Biotech ,
San Diego Based ,
Medicxi Partner Francesco De Rubertis ,
comparemela.com © 2020. All Rights Reserved.